Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

This study has been completed.

Study NCT00003384 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: April 12, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)

Publications:

Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Darcy KM, Carter R, Levine L, Spirtos NM, Susumu N, Fujiwara K, Walker JL, Hatae M, Stanbridge EJ. Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study. Br J Cancer. 2010 Dec 14; [Epub ahead of print]

Liao SY, Rodgers WH, Bonfiglio T, et al.: Carbonic anhydrase IX (CAIX) and human papillomavirus (HPV) as potential diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells of undetermined significance (AGUS): a Gynecologic Oncology Group (GOG) study. [Abstract] United States and Canadian Academy of Pathology 96th Annual Meeting, March 24-30, 2007, San Diego, CA. A-321, 2007.